ITI Pharma and Healthcare Fund Regular vs HDFC Pharma and Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹217 Cr | ₹1568 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 08 Nov 2021 | 04 Oct 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Dhruv Muchhal |
ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Month | -7.34% | -5.74% |
6 Month | -6.6% | -1.25% |
1 Year | 9.8% | 21.28% |
3 Year | 17.76% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
6 Month | - | - |
1 Year | 0.25% | 13.16% |
3 Year | 21.16% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Year | 24.79% | 51.48% |
3 Year | 19.26% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Standard Deviation | 15.667% | - |
Sharp | 0.739% | - |
Beta | 0.959% | - |
Alpha | -1.413% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Name | Rohan Korde | Dhruv Muchhal |
Total AUM | ₹4626 Cr | ₹520687 Cr |
Fund Manage | 10 | 40 |
ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 1.8 | 1.98 |
Large Cap | 38.11 | 32.5 |
Mid Cap | 26.43 | 32.4 |
Small Cap | 33.66 | 33.12 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 1.8 | 1.98 |
Pharmaceuticals & Biotechnology | 77 | 74.71 |
Healthcare Services | 18.01 | 22.28 |
Chemicals & Petrochemicals | 0.96 | - |
Fertilizers & Agrochemicals | 1.03 | - |
Insurance | 1.2 | - |
Retailing | - | 1.03 |
Top Comparisons
HDFC Banking and Financial Services Fund - Growth Option
3Y Returns12.62%
Mirae Asset Banking and Financial Services Fund Regular Growth
3Y Returns12.2%
SBI NIFTY50 EQUAL WEIGHT INDEX FUND REGULAR PLAN GROWTH
3Y Returns0%
Canara Robeco Blue Chip Equity Fund - Regular Plan - Growth Option
3Y Returns11.78%
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns7.95%
Aditya Birla Sun Life Equity Savings Fund - Regular Plan - Growth
3Y Returns6.77%
Nippon India Dynamic Bond Fund-Growth Plan-Growth Option
3Y Returns6.3%
PGIM India Dynamic Bond Fund - Growth Option
3Y Returns5.99%